期刊文献+

1,4,5-三磷酸肌醇受体与心血管疾病 被引量:1

The research of inositol 1,4,5-triphosphate receptor and cardiovascular disease
下载PDF
导出
摘要 1,4,5-三磷酸肌醇受体是一种细胞内Ca2+释放通道,它与1,4,5-三磷酸肌醇结合后,引起Ca2+浓度发生改变,从而参与钙信号转导,调节多种细胞代谢活动。近年来,越来越多的研究提示其参与心力衰竭、心肌肥厚、心房颤动等心血管疾病的发生。现就三磷酸肌醇受体的结构、分布、激活Ca2+通道开放以及与心血管疾病发病机制的研究进展等作一综述。 Inositol 1,4,5-trisphosphate receptor (IP3 R) functions as an intracellular Ca^2+ channel. It participates in the pathways of calcium-induced signal transduction and regulations of cellular activity through a change in intracellular Ca^2+ concentration when binding to its ligand, inositol 1,4,5-trisphosphate (IP3 ). In recent years, increasingly researches have shown that IP3 Rs played a vital role in the development of some cardiovascular disease, especially in heart failure, myocardial hypertrophy and atrial fibrillation. In this review, the recent advancement in structure and distribution of IP3 R, the mechanism it activates Ca^2+ channel and its relationship with cardiovascular disease are discussed.
出处 《国际内科学杂志》 CAS 2007年第5期253-256,共4页 International Journal of Internal Medicine
关键词 三磷酸肌醇受体 钙超载 钙信号 心血管疾病 Inositol 1,4,5-trisphosphate receptors Calcium Calcium overload Calcium signal Cardiovascular disease
  • 相关文献

参考文献1

二级参考文献25

  • 1Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy.J Mol Med 1998; 76: 725-46.
  • 2Yamamoto K, Dang QN, Maeda Y, Huang H, Kelly RA, Lee RT.Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation 2001; 103: 1459-64.
  • 3Wettschureck N, Riitten H, Zywietz A, Gehring D, Wilkie TM,Chen J, et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat Med 2001; 7: 1236-40.
  • 4Sabri A, Wilson BA, Steinberg SF. Dual actions of the Gαq agonist pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res 2002;90: 850-7.
  • 5Crabtree GR. Generic signals and specific outcomes: signaling through Ca^2+, calcineurin, and NF-AT. Cell 1999; 96: 611-4.
  • 6Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97: 1196-201.
  • 7Blaeser F, Ho N, Prywes R, Chatila TA. Ca^2+-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem 2000; 275: 197-209.
  • 8Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 2003; 92: 1079-88.
  • 9Muth JN, Bodi I, Lewis W, Varadi G, Schwartz A. A Ca^2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 2001; 103: 140-7.
  • 10De Windt LJ, Lim HW, Haq S, Force T, Molkentin JD. Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem 2000; 275: 13571-9.

共引文献3

同被引文献23

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部